Development · 28 Sep 2026

The medium-term growth for Laurus Labs will be largely driven by CDMO projects across human health, animal health, and crop science areas.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

moneycontrol.com28 Sep 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Laurus Labs

₹1,984.00

▲ +0.20%

Close (EOD), as of 1 Oct 2026 · source

Laurus Labs: results, dividends, orders, the full cited record →

More on Laurus Labs

Dr Reddys Laboratories Ltd is quoting at Rs 1213, up 0.17% on the day as on 12:44 IST on the NSE.

24 Sep 2026 · 2 publishers

The CAS window recorded $4.2 billion turnover on Monday as investors executed trades linked to MSCI's India index rebalancing, accounting for 22% of NSE's total cash market turnover.

1 Sep 2026 · 1 publisher

Lenskart, Adani Energy, Groww and Laurus Labs will be added to the MSCI index effective from the closing of trading on August 31.

31 Aug 2026 · 1 publisher

Laurus Labs Ltd stock price rose 1.23% to Rs 1910.3 on NSE as of 12:49 IST on August 27, 2026, and has gained 121.61% over the past one year.

27 Aug 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.